Gout clinical trials
The registry lists 232 studies for Gout across more than 10 countries. 45 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-22.
Status
- Completed
- 139
- Recruiting
- 28
- Status unknown
- 18
- Not yet recruiting
- 15
- Active, not recruiting
- 14
- Terminated
- 11
Phase
- Phase 2
- 68
- Phase 3
- 48
- Phase 4
- 29
- Phase 1
- 20
- Early Phase 1
- 1
Where
- United States
- 108
- China
- 29
- Taiwan
- 16
- Canada
- 16
- Australia
- 15
- France
- 15
Who runs them
Ardea Biosciences, Inc. (14) · Takeda (10) · Assistance Publique - Hôpitaux de Paris (8) · Amgen (7) · Regeneron Pharmaceuticals (7) · Arthrosi Therapeutics (6) · Atom Therapeutics Co., Ltd (5) · Gilead Sciences (5)
Studies
Recruiting first, then most recently updated. Showing 50 of 232 — search for more.
- Evaluation of the Impact of Dietary Education and Intervention on Gout Patients Receiving Urate-Lowering TherapyEnrolling by invitationNCT07834840Not applicable1 country
- Mazdutide for Weight Management and Gout in Adults With ObesityNot yet recruitingNCT07824895Phase 4
- A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsRecruitingNCT07535034Phase 21 country
- A Study of Dotinurad Versus Allopurinol in Participants With GoutRecruitingNCT07089875Phase 33 countries
- The Correlation Between Sodium Urate (MSU) Deposition and Coronary Atherosclerosis in Patients With Foot GoutNot yet recruitingNCT077840491 country
- SAVE-Care (Sodium Glucose Cotransporter-2 Inhibitors [SGLT2i] As Novel Gout Care) TrialRecruitingNCT06674109Phase 41 country
- A Study of IN026 in Participants With Refractory GoutRecruitingNCT07587684Phase 11 country
- The Impact of Initiating Dotinurad Urate-Lowering Therapy at Different Time Windows on Gout Flare Resolution TimeNot yet recruitingNCT07661030Phase 4
- Musculoskeletal Ultrasound for Differentiating Rheumatoid and Gouty ArthritisNot yet recruitingNCT07657156
- A Study to Investigate the Clinical Effect and the Safety of PRX-115 Infused Intravenously at Different Dosing Regimens, With and Without Methotrexate, Versus Placebo in Adults Gout Patients (RELEASE)RecruitingNCT07280156Phase 23 countries
- Immediate Prescription of a Hypouricemic Treatment, Febuxostat, Compared to Its Delayed AdministrationRecruitingNCT05109936Phase 31 country
- Probiotic-Uricase Complex Preparation for Improving Uric Acid Metabolism in Patients With HyperuricemiaNot yet recruitingNCT07613164Not applicable
- The Remote Monitoring of Gout Feasibility Study in Primary CareRecruitingNCT07490522Not applicable1 country
- the Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or MoreRecruitingNCT06622603Phase 41 country
- Drug-Drug Interaction Study of ABP-671 in Gout PatientsRecruitingNCT07367971Phase 11 country
- Dose Response of Exercise for Arthritis ManagementRecruitingNCT06880653Not applicable1 country
- The Orienting StudyRecruitingNCT075041461 country
- Clinical Trial of BR2251 Tablets for Patients With Primary Gout and HyperuricemiaNot yet recruitingNCT07498647Phase 2
- Study of Dapansutrile Tablets in Subjects With an Acute Gout FlareRecruitingNCT05658575Phase 2/35 countries
- Pharmacist-Led Treat-to-Target Urate Lowering Therapy in Patients With GoutNot yet recruitingNCT06887452Not applicable1 country
- Time Required to Dissolve Urate DepositsRecruitingNCT066690001 country
- HLA-B*58:01-Guided Therapy for Gout: Effectiveness, Safety, and Cost-EffectivenessNot yet recruitingNCT07369622Phase 4
- Acute Effects of a Urate-lowering Bacterial Therapeutic on Small Intestinal Transcriptomics and Glycomics in Healthy SubjectsNot yet recruitingNCT07366749Not applicable1 country
- Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout FlaresRecruitingNCT07346079Phase 41 country
- Improving Gout Care After an ED VisitRecruitingNCT06534554Not applicable1 country
- Orlistat and Weight Management for Uric Acid Control in Obese Gout: A RCTNot yet recruitingNCT07326839Not applicable1 country
- A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.RecruitingNCT06298071Phase 11 country
- Effect of Dotinurad in Hyperuricemia With HypertensionRecruitingNCT06834230Phase 41 country
- Safety and Efficacy of ABP-745 in Participants With an Acute Gout FlareRecruitingNCT07145229Phase 23 countries
- Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in GoutRecruitingNCT04875702Phase 41 country
- Clinical Efficacy Trial of Burdock Root Extract in Patients With Asymptomatic HyperuricaemiaRecruitingNCT07002762Not applicable1 country
- Developing A Gout Action Plan in Primary Care Setting in SingaporeNot yet recruitingNCT07061587Not applicable1 country
- Metformin in Safety and Efficacy in Gouty PatientsRecruitingNCT06924658Phase 21 country
- The Remote Monitoring of Gout StudyEnrolling by invitationNCT06822933Not applicable1 country
- Safety, Tolerability, and Pharmacokinetic Characteristics of SSS11 in Patients With Gout and HyperuricemiaRecruitingNCT06629376Phase 11 country
- Exploratory Study on the Treatment of Gout With Potassium Citrate Sustained-release TabletsRecruitingNCT06966635Phase 41 country
- Maintenance or Withdrawal of Urate Lowering Therapy According to Ultrasound Features in Gout Patients: a Randomised Controlled Trial Stop Treatment In GoutNot yet recruitingNCT06956885Phase 2
- Efficacy Anda Safety of Etoricoxib With Betamethasone for the Treatment of Acute Gout ArthritisRecruitingNCT06863701Phase 31 country
- Prevalence of Abnormalities in Ultrasonography of Joint and Tendons in Patients With GoutRecruitingNCT055465931 country
- Assessment of Physician Consideration of EPRO's, from Patients with Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic AdjustmentsRecruitingNCT059276881 country
- Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2RecruitingNCT066940121 country
- Study on the Efficacy and Safety of Thermotherapy in the Treatment of Refractory GoutNot yet recruitingNCT06653686Not applicable
- The Effects of Limb Elevation During Gout Flare EpisodesNot yet recruitingNCT06207045Not applicable1 country
- A Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute GoutNot yet recruitingNCT06169891Phase 3
- Probiotics for Gout / Hyperuricemia: A Randomized, Intervention, Parallel Controlled, Multicenter Clinical TrialRecruitingNCT04199325Not applicable1 country
- A Non-Interventional Pilot Study to Explore the Role of Gut Flora in DiseaseSuspendedNCT040314691 country
- Safety and Efficacy Study of MBX-102 in Treatment of Hyperuricemia in Patients With GoutCompletedNCT01336686Phase 21 country
- Evaluate the PK, PD, and Safety of Arhalofenate in Combination With Febuxostat for Hyperuricemia in Patients With GoutCompletedNCT02252835Phase 21 country
- Comparative Clinical and Biochemical Study Evaluating the Effectiveness of Metformin Versus Febuxostat on Gouty Obese Non-Diabetic PatientsCompletedNCT06995339Phase 21 country
- A Trial to Investigate the Non-inferiority of Pegloticase Administered Every 4 Weeks (Q4W) With MTX Compared With Every 2 Weeks (Q2W) With MTX in Participants With Uncontrolled Refractory GoutCompletedNCT06229145Phase 41 country